Intas B2B

Intas B2B

Fabricación de productos farmacéuticos

Expressions For A Healthy Life

Sobre nosotros

Intas Pharmaceuticals Ltd. is a vertically integrated global company, leading in the development, manufacturing and marketing of pharmaceutical formulations, including Generics, Biosimilars and Added Value Medicines. It has been growing at about 13% CAGR over the last five years and crossed the $2.5 billion mark in the past financial year. Intas is present in 85 countries worldwide including the highly regulated markets of EU, U.S., Canada, South Africa, Australia, Asia Pacific as well as CIS & MENA regions. Intas manufactures tablets, capsules, effervescent tablets, ointments for high potency drugs, oncology orals and oncology injectables, including pre-filled syringes through fifteen formulation manufacturing facilities, of which ten are located in India, and the rest in the U.K, Mexico, & Greece. The facilities are accredited by top global regulators such as USFDA, EMA, MHRA and TGA. R&D is the key growth driver for Intas with more than 300 projects in the pipeline and a focus on added-value products, biosimilars and first-to-market opportunities. Intas dedicates more than 1,000 scientific personnel to R&D activities, from a total workforce of 19,000 employees. Since March 2005, Intas B2B has consolidated its customer partnerships and is present in over 70 countries, with more than 100 partners and 150 products in its portfolio (Generics, Biosimilars and Added Value Medicine). Intas B2B is very active in Europe and other regions such as Canada, Australia, LATAM, ASIA and the Middle East. Intas B2B is composed of a full-fledged, global support team of 50 people (from Global offices in Barcelona and around the globe) to cover the demand of its valued customers. For more information, visit www.intaspharma.com For more detailed product information, please register at www.intasportfolio.com

Sitio web
https://intasb2b.com
Sector
Fabricación de productos farmacéuticos
Tamaño de la empresa
De 11 a 50 empleados
Sede
Barcelona
Fundación
2005
Especialidades
Genéricos, Biosimilares, Added Value Medicines y out-licensing

Actualizaciones

Páginas asociadas

Páginas similares